MEHA

Company Overview — What Does Functional Brands Inc. Do?

Our company operates in the nutraceutical supplement industry. We are a manufacturer and distributor of supplements in categories such as pain, energy, prenatal, general health, bone and joint, gastro, immunity, cardiac, detox, mental clarity & focus, sleep, prenatal and urinary. Our end markets focus on end-consumers through different channels that include pharmacies, US wholesalers, international distributors and direct-to-consumers sales. Our products are sold over the counter, and consumers do not need a prescription to purchase our products. Our products are not approved by the FDA. Our company also operates in the hemp industry as a retailer of hemp derived products in categories such as capsules, cigarettes, gummies, and tinctures with a commercial end market, and end-consumers. Our Products Kirkman Brand Our “Kirkman” brand products are manufactured in our FDA registered, cGMP certified facility in Lake Oswego, Oregon. Established in 1949, Kirkman specializes in manufacturing nutritional supplements and is one of the oldest companies dedicated to serving the special needs community. Our Kirkman brand offers more than 150 products, including probiotics, enzymes, vitamins, multivitamins, amino acids, antioxidants, immune support, essential fatty acids, preconception, prenatal supplements, personal care products and other specialty products. Kirkman treats patients with autism spectrum disorders and special dietary needs through an established network of over 2,000 doctors in over 40 countries. Our Kirkman brand operates in 95% of the major subsegments in the supplement industry. Kirkman has a long-standing loyal customer and consumer base due to the rigorous testing of products in compliance with FDA requirements. Kirkman has been endorsed by various businesses and celebrities, including the famous and original Shark Tank member, Kevin Harrington. Digestive enzymes: Over the counter oral digestive enzyme supplements are a combination of proteases, which aid protein digestion; lipases, which aid in fat digestion; and amylases, which aid in carbohydrate digestion. These may be prescribed by a doctor in some cases, when the pancreas does not make enough digestive enzymes on its own. People are increasingly taking over the counter (“OTC”) digestive enzymes in lower doses to support general gut health. Essential fatty acids: Also called omega-3 fatty acids, essential fatty acids are important digestive chemicals that the body cannot make on its own. Our products under the Kirkman Brand include, but are not limited to, the following: . Supplements for Autism; . Essential Fatty Acids; . Oxytocin; . Vitamin B12; . Vitamin B6 and Magnesium; . Glutathione; . Melatonin; . Functional Mushrooms; . Probiotics; . Multivitamins and Minerals; and . Digestive Enzymes; . Antioxidants. . Amino Acids; P2i (prenatal) Brand We launched a certified prenatal vitamin in April 2024 for expectant mothers under the P2i by Kirkman brand. These vitamins have been specially formulated by our company to provide essential nutrients for both the mother and the developing fetus. The International Federation of Gynecology and Obstetrics (“FIGO”) published a position statement about toxic chemicals and environmental contaminants in prenatal vitamins. FIGO’s recommendation from the October 2023 position statement highlights that patients should only consume, and clinicians should only prescribe, vitamins and supplements that have been independently assessed to make certain they do not contain contaminants. Manufacturers should be held to a standard of production that assures safety and minimizes contaminants and certification of all prenatal vitamins becomes the standard of care. The FIGO Committee report on Climate Change and Toxic Environmental Exposures brought together global scientists to review reputable reference sources for chemicals that have the potential to impact maternal and newborn health, including the USA Environmental Protection Agency, the European Union, and the California EPA. The group of experts recommended several approaches, including: 1. creating a list of toxic chemicals and contaminants that should be screened for in Prenatal Vitamins and reduced to de minimis standards; and 2. conducting assays of existing vitamins to assess ongoing risk to maternal and newborn health. This work can extend to personal exposure risk by offering women testing for the presence of potentially toxic environmental chemicals. Mass Spectrometry currently offers the most comprehensive measurement. This first publication of a list of toxic chemicals and contaminants represents the most comprehensive testing available at present but does not purport to identify or eliminate all potential sources of toxicity. We are currently the only certified prenatal vitamin in the market that aligns to the FIGO position statement. We have formulated and produced a prenatal vitamin called P2i by Kirkman. There are approximately 3.6 million pregnancies alone in the United States (https://www.cdc.gov/nchs/fastats/births.htm) and the initial market focus for this product will be the United States with the expectation to expand globally since FIGO’s position statement reaches all countries. The P2i by Kirkman prenatal vitamin has been certified by The FORUM, a nonprofit 501(c)(3) organization dedicated to promoting low-toxicity standards for prenatal healthy products. The FORUM operates under a Memorandum of Understanding (MOU) with FIGO, a globally recognized organization of obstetricians and gynecologists. This MOU establishes a shared objective to reduce environmental toxicity in prenatal products. . The certification process involves rigorous testing and evaluation to ensure compliance with The FORUM’s low-toxicity standards, which align with FIGO’s objectives for maternal and fetal health. These standards include: . Analysis of 24 Heavy Metals, ensuring levels are below stringent safety thresholds . Testing for the presence of 120 toxic chemicals, such as pesticides and endocrine disruptors, with strict limits to prevent potential harm . Utilization of ISO 17025-accredited laboratories for all testing to ensure reliability and reproducibility of results . Purity Labs, an ISO 17025-accredited laboratory, as directed by The FORUM, conducted testing, which confirmed the product’s compliance with The FORUM’s criteria. Based on this testing, The FORUM issued its certification, indicating that Kirkman’s prenatal vitamin meets its standards for low toxicity and safety. HempTown Naturals Brand All HempTown Naturals products are produced and sold in compliance with the US 2018 Farm Bill and the US Agricultural Act of 2014. Cannabidiol (“CBD”) and cannabigerol (“CBG”) are cannabinoids present in the cannabis plant. Both CBD and CBG are used in hemp derived products. These products are believed to help in treating certain neurodegenerative and inflammatory conditions(1). CBD CBD is the second most prevalent ingredient in cannabis. While CBD is an integral component of medical marijuana, it is derived directly from the hemp plant, both of which are the same species of Cannabis sativa L. One of the hundreds of components of Cannabis sativa L., CBD does not cause a “high” by itself. According to a report from the World Health Organization, “In humans, CBD exhibits no effects indicative of any abuse or dependence potential. To date, there is no evidence of public health related products associated with the use of pure CBD”(2). As reported by Forbes Health, CBD is applied topically or consumed through smoke inhalation or edible consumption. CBD interacts with neuroreceptors in your endocannabinoid system, which sends signals between your cells to help regulate your movement, mood, homeostasis, and immune system. Different studies have shown that CBD can offset everyday anxiety and depression(3). CBG CBG is another compound found in hemp which doesn’t have intoxicatingly psychoactive effects. CBG, often referred to by experts as “the mother of all cannabinoids,” is the cannabinoid from which other types of cannabinoids (including CBD) are derived, says Michelle Sexton, a naturopathic doctor who works at the Pain Trauma Institute in San Diego. “CBG is the first compound in the biosynthesis (the production of chemical compounds by a living organism) of the other cannabinoids,” she adds. CBG is available in many forms, including tinctures, gummies, capsules and topical creams and lotions. CBG is often coupled with CBD in these products because the two cannabinoids can provide complimentary benefits, such as decreasing inflammation and pain, says Fraser Smith, a naturopathic doctor, as well as assistant dean and associate professor at the National University of Health Services in Lombard, Illinois. CBD and CBG occur naturally in hemp extract which is the source of our cannabinoids(4). Golf Mellow Brand The Company has utilized existing product formulations with plans to introduce 12 different products under the Golf Mellow brand. A brand logo and packaging has been created to support the existing formulations. These supplements will be targeting the golf industry and golf professionals. These products include capsules, a powder, a cream and tinctures to help golfers of all levels improve their game and overall well-being. The capsules are packed with a blend of essential vitamins and minerals that support joint health, flexibility, and energy levels. The tinctures are made from all-natural ingredients and provide a quick and easy way to support focus and mental clarity, helping athletes stay in the zone and make the perfect shot. The creams are specially designed to provide targeted relief for sore muscles and joints, helping them stay comfortable and focused on the course. Some of these products include Sleep Caps to ensure that players are well rested the night before, Super B12 Powder which provides the energy needed for the perfect round, Calm Caps which help manage anxiety when players need it most, and Epsom Salt Cream & Recovery Caps, which aids with recovery. According to data from the National Golf Foundation 28.1 million people (aged six and over) played on a golf course in the United States in 2024 – furthermore there were another 19.1 million people who took part in off-course activities like driving ranges, indoor golf simulators or venues like Topgolf(5). We are currently incorporated and in good standing in the State of Delaware. Our registered address is in Lake Oswego, Oregon. Functional Brands Inc. (MEHA) is classified as a micro-cap stock in the Healthcare sector, specifically within the Pharmaceutical Products industry. The company is led by CEO Eric Gripentrog and employs approximately 33 people, headquartered in WEST HOLLYWOOD, California. With a market capitalization of $3M, MEHA is one of the notable companies in the Healthcare sector.

Functional Brands Inc. (MEHA) Stock Rating — Avoid (April 2026)

As of April 2026, Functional Brands Inc. receives a Avoid rating with a composite score of 19.0/100 and 1 out of 5 stars from the Blank Capital Research quantitative model.MEHA ranks #4,378 out of 4,446 stocks in our coverage universe. Within the Healthcare sector, Functional Brands Inc. ranks #813 of 838 stocks, placing it in the lower half of its Healthcare peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).

MEHA Stock Price and 52-Week Range

Functional Brands Inc. (MEHA) currently trades at $0.16. The stock lost $0.01 (3.3%) in the most recent trading session. Recent trading volume was 1.1M shares, reflecting moderate market activity.

Is MEHA Overvalued or Undervalued? — Valuation Analysis

Functional Brands Inc. (MEHA) carries a value factor score of 27/100 in the Blank Capital model, signaling premium valuation that prices in significant future growth. The trailing price-to-earnings ratio is 2.13x, compared to the Healthcare sector average of 23.63x — a discount of 91%. The price-to-book ratio stands at 2.69x, versus the sector average of 2.75x. The price-to-sales ratio is 0.16x, compared to 1.66x for the average Healthcare stock.

At current multiples, Functional Brands Inc. trades at a premium to most Healthcare peers. This elevated valuation may be justified if the company can sustain above-average growth rates and profitability, but it also creates downside risk if earnings disappoint expectations.

Functional Brands Inc. Profitability — ROE, Margins, and Quality Score

Functional Brands Inc. (MEHA) earns a quality factor score of 10/100, signaling below-average profitability metrics relative to the broader market. The return on equity (ROE) is 196.8%, compared to the Healthcare sector average of -43.5%, which demonstrates strong shareholder value creation. Return on assets (ROA) comes in at 33.3% versus the sector average of -33.1%.

On a margin basis, Functional Brands Inc. reports gross margins of 52.7%, compared to 71.5% for the sector. The operating margin is -21.1% (sector: -66.1%). Net profit margin stands at 11.5%, versus -58.7% for the average Healthcare stock. Profitability is below benchmark levels, which may reflect industry headwinds, elevated reinvestment, or structural challenges.

MEHA Debt, Balance Sheet, and Financial Health

Functional Brands Inc. has a debt-to-equity ratio of 9.0%, compared to the Healthcare sector average of 32.0%. The low leverage indicates a conservative balance sheet with significant financial flexibility. The current ratio is 0.90x, which may signal near-term liquidity tightness. Total debt on the balance sheet is $140,468.

MEHA has a beta of 3.64, meaning it is more volatile than the broader market — a $10,000 investment in MEHA would be expected to move 264.0% more than the S&P 500 on any given day. The stability factor score for Functional Brands Inc. is 10/100, suggesting elevated price swings that may be unsuitable for conservative portfolios.

Functional Brands Inc. Revenue and Earnings History — Quarterly Trend

In TTM 2026, Functional Brands Inc. reported revenue of $7M and earnings per share (EPS) of $0.08. Net income for the quarter was $758,478. Gross margin was 52.7%. Operating income came in at $-1M.

In FY 2025, Functional Brands Inc. reported revenue of $7M and earnings per share (EPS) of $0.08. Net income for the quarter was $758,478. Gross margin was 52.7%. Operating income came in at $-1M.

MEHA Dividend Yield and Income Analysis

Functional Brands Inc. (MEHA) does not currently pay a dividend. This is common among smaller companies in the Pharmaceutical Products industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Healthcare dividend stocks may want to explore other Healthcare stocks or use the stock screener to filter by dividend yield.

MEHA Momentum and Technical Analysis Profile

Functional Brands Inc. (MEHA) has a momentum factor score of 23/100, signaling weak relative price performance. Stocks with low momentum scores have historically tended to continue underperforming in the near term. The investment factor score is 25/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 27/100 signals elevated short interest, which can indicate bearish sentiment among institutional investors.

MEHA vs Competitors — Healthcare Sector Ranking and Peer Comparison

Within the Healthcare sector, Functional Brands Inc. (MEHA) ranks #813 out of 838 stocks based on the Blank Capital composite score. This places MEHA in the lower half of all Healthcare stocks in our coverage universe. Key competitors and sector peers include ASTRAZENECA PLC (AZN) with a score of 61.4/100, Sol-Gel Technologies Ltd. (SLGL) with a score of 56.6/100, VIEMED HEALTHCARE, INC. (VMD) with a score of 53.4/100, Innoviva, Inc. (INVA) with a score of 52.7/100, and JOHNSON & JOHNSON (JNJ) with a score of 51.7/100.

Comparing MEHA against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full MEHA vs S&P 500 (SPY) comparison to assess how Functional Brands Inc. stacks up against the broader market across all factor dimensions.

MEHA Next Earnings Date

No upcoming earnings date has been announced for Functional Brands Inc. (MEHA) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.

Should You Buy MEHA? — Investment Thesis Summary

The quantitative profile for Functional Brands Inc. suggests caution. The quality score of 10/100 flags below-average profitability. The value score of 27/100 indicates premium valuation. Momentum is weak at 23/100, a headwind for near-term performance. High volatility (stability score 10/100) increases portfolio risk.

In summary, Functional Brands Inc. (MEHA) earns a Avoid rating with a composite score of 19.0/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on MEHA stock.

Related Resources for MEHA Investors

Explore more research and tools: MEHA vs S&P 500 comparison, top Healthcare stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare MEHA head-to-head with peers: MEHA vs AZN, MEHA vs SLGL, MEHA vs VMD.